27 May 2023 : Clinical Research
Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease
Egle Audronyte 1ABCDEF*, Vaiva Sutnikiene1BCEF, Gyte Pakulaite-Kazliene1CDEF, Gintaras Kaubrys 1ABCDEFDOI: 10.12659/MSM.940363
Med Sci Monit 2023; 29:e940363
Table 3 Results of the odor identification test.
Odor | NC correct responses (%) | MCI-AD correct responses (%) | MD-AD correct responses (%) |
---|---|---|---|
Clove,a | 30 (100.00) | 19 (63.33)* | 18 (60.00)* |
Fish | 29 (96.67) | 28 (93.33) | 20 (66.67)* |
Orange | 29 (96.67) | 23 (76.67) | 19 (63.33)* |
Garlicb | 29 (96.67) | 22 (73.33) | 17 (56.67)* |
Coffee | 28 (93.33) | 24 (80.00) | 19 (63.33)* |
Cinnamonb | 28 (93.33) | 19 (63.33)* | 10 (33.33)* |
Peppermint | 27 (90.00) | 24 (80.00) | 16 (53.33)* |
Rose | 27 (90.00) | 22 (73.33) | 15 (50.00)* |
Bananab | 26 (86.67) | 16 (53.33)* | 7 (23.33)* |
Anis | 25 (83.33) | 19 (63.33) | 17 (56.67) |
Turpentine | 22 (73.33) | 12 (40.00) | 16 (53.33) |
NC – normal cognition; AD – Alzheimer disease; MCI-AD – mild cognitive impairment due to Alzheimer disease; MD-AD – mild dementia due to Alzheimer disease. * Significantly different from the NC group 0.016). a The odor that differed the most ( b The odors that differed the most ( |